Sangamo Therapeutics
SGMO
SGMO
141 hedge funds and large institutions have $448M invested in Sangamo Therapeutics in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 44 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 44
Holders
141
Holding in Top 10
1
Calls
$28.4M
Puts
$3.02M
Top Buyers
| 1 | +$13.9M | |
| 2 | +$7.76M | |
| 3 | +$7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.22M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$2.74M |
Top Sellers
| 1 | -$21.7M | |
| 2 | -$7.57M | |
| 3 | -$6.15M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.87M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.78M |